Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 May;84(10):1317–1321. doi: 10.1054/bjoc.2001.1790

Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas

T Masaki 1, H Matsuoka 1, M Sugiyama 1, N Abe 1, A Goto 2, A Sakamoto 2, Y Atomi 1
PMCID: PMC2363635  PMID: 11355941

Abstract

Matrix metalloproteinases play a crucial role in tumour invasion and mestasis. Matrilysin (MMP-7) has been shown to correlate with nodal or distant metastasis in colorectal carcinomas; however, its implication in early invasive colorectal carcinomas has not been determined. This study was undertaken to clarify the association of matrilysin expression with clinicopathologic parameters in early invasive colorectal carcinomas. 38 early invasive colorectal carcinomas treated by local excision or radical surgery were examined. Tumour budding was evaluated as the number of dedifferentiation units along the entire invasive margin. Matrilysin protein levels were determined using immunohistochemical study. Univariate analysis showed that matrilysin expression alone was significantly associated with distant metastasis (P= 0.0339), and both tumour budding and matrilysin expression were significantly associated with adverse outcome (P= 0.0005, 0.0341). Histological differentiation, vessel invasion, and depth of invasion were not significantly associated with either distant metastasis or adverse outcome. Multivariate analysis confirmed that tumour budding and matrilysin expression were independently associated with adverse outcome, although the significance of matrilysin expression was marginal (P= 0.0488). Tumour budding at the invasive margin and matrilysin expression are more useful in identifying high-risk groups for adverse outcome in patients with early invasive colorectal carcinomas. © 2001 Cancer Research Campaign www.bjcancer.com

Keywords: matrilysin, colorectal carcinoma, budding, tumour invasion, metastasis

Full Text

The Full Text of this article is available as a PDF (194.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi Y., Itoh F., Yamamoto H., Matsuno K., Arimura Y., Kusano M., Endoh T., Hinoda Y., Oohara M., Hosokawa M. Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers. Int J Oncol. 1998 Nov;13(5):1031–1035. doi: 10.3892/ijo.13.5.1031. [DOI] [PubMed] [Google Scholar]
  2. Adachi Y., Yamamoto H., Itoh F., Hinoda Y., Okada Y., Imai K. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut. 1999 Aug;45(2):252–258. doi: 10.1136/gut.45.2.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brabletz T., Jung A., Dag S., Hlubek F., Kirchner T. beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 1999 Oct;155(4):1033–1038. doi: 10.1016/s0002-9440(10)65204-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Christie J. P. Polypectomy or colectomy? Management of 106 consecutively encountered colorectal polyps. Am Surg. 1988 Feb;54(2):93–99. [PubMed] [Google Scholar]
  5. Colacchio T. A., Forde K. A., Scantlebury V. P. Endoscopic polypectomy: inadequate treatment for invasive colorectal carcinoma. Ann Surg. 1981 Dec;194(6):704–707. doi: 10.1097/00000658-198112000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cooper H. S. Surgical pathology of endoscopically removed malignant polyps of the colon and rectum. Am J Surg Pathol. 1983 Oct;7(7):613–623. doi: 10.1097/00000478-198310000-00002. [DOI] [PubMed] [Google Scholar]
  7. Cranley J. P., Petras R. E., Carey W. D., Paradis K., Sivak M. V. When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology. 1986 Aug;91(2):419–427. doi: 10.1016/0016-5085(86)90577-9. [DOI] [PubMed] [Google Scholar]
  8. Crawford H. C., Matrisian L. M. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis. 1994;14(1-6):234–245. [PubMed] [Google Scholar]
  9. Haggitt R. C., Glotzbach R. E., Soffer E. E., Wruble L. D. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology. 1985 Aug;89(2):328–336. doi: 10.1016/0016-5085(85)90333-6. [DOI] [PubMed] [Google Scholar]
  10. Hase K., Shatney C., Johnson D., Trollope M., Vierra M. Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum. 1993 Jul;36(7):627–635. doi: 10.1007/BF02238588. [DOI] [PubMed] [Google Scholar]
  11. Marks J. W., Uhler M. L., Bonorris G. G., Judd H. L. Nucleation of biliary cholesterol, arachidonate, prostaglandin E2, and glycoproteins in postmenopausal women. Gastroenterology. 1997 Apr;112(4):1271–1276. doi: 10.1016/s0016-5085(97)70140-9. [DOI] [PubMed] [Google Scholar]
  12. Masaki T., Muto T. Predictive value of histology at the invasive margin in the prognosis of early invasive colorectal carcinoma. J Gastroenterol. 2000;35(3):195–200. doi: 10.1007/s005350050330. [DOI] [PubMed] [Google Scholar]
  13. Miyazaki K., Hattori Y., Umenishi F., Yasumitsu H., Umeda M. Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line. Cancer Res. 1990 Dec 15;50(24):7758–7764. [PubMed] [Google Scholar]
  14. Morson B. C., Bussey H. J., Samoorian S. Policy of local excision for early cancer of the colorectum. Gut. 1977 Dec;18(12):1045–1050. doi: 10.1136/gut.18.12.1045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Morson B. C., Whiteway J. E., Jones E. A., Macrae F. A., Williams C. B. Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut. 1984 May;25(5):437–444. doi: 10.1136/gut.25.5.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Muto T., Sawada T., Sugihara K. Treatment of carcinoma in adenomas. World J Surg. 1991 Jan-Feb;15(1):35–40. doi: 10.1007/BF01658958. [DOI] [PubMed] [Google Scholar]
  17. Ono M., Sakamoto M., Ino Y., Moriya Y., Sugihara K., Muto T., Hirohashi S. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis. Cancer. 1996 Sep 15;78(6):1179–1186. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1179::AID-CNCR3>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  18. Stetler-Stevenson W. G., Aznavoorian S., Liotta L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol. 1993;9:541–573. doi: 10.1146/annurev.cb.09.110193.002545. [DOI] [PubMed] [Google Scholar]
  19. Wilson C. L., Matrisian L. M. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol. 1996 Feb;28(2):123–136. doi: 10.1016/1357-2725(95)00121-2. [DOI] [PubMed] [Google Scholar]
  20. Woessner J. F., Jr, Taplin C. J. Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem. 1988 Nov 15;263(32):16918–16925. [PubMed] [Google Scholar]
  21. Yamamoto H., Adachi Y., Itoh F., Iku S., Matsuno K., Kusano M., Arimura Y., Endo T., Hinoda Y., Hosokawa M. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res. 1999 Jul 15;59(14):3313–3316. [PubMed] [Google Scholar]
  22. Yamashita K., Azumano I., Mai M., Okada Y. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis. Int J Cancer. 1998 Apr 17;79(2):187–194. doi: 10.1002/(sici)1097-0215(19980417)79:2<187::aid-ijc15>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES